A 21-YEAR EXPERIENCE WITH MAJOR HEMORRHAGE AFTER PERCUTANEOUS LIVER-BIOPSY
A 21-YEAR EXPERIENCE WITH MAJOR HEMORRHAGE AFTER PERCUTANEOUS LIVER-BIOPSY
复制标题
DOI：
10.1016/0016-5085(90)91167-5
复制
发表时间：
1990-11-01
期刊：
影响因子：
29.4
通讯作者：
OTT, BJ
中科院分区：
文献类型：
--
作者：
MCGILL, DB;RAKELA, J;OTT, BJ
根据规定的方案进行了9212例肝活检，并前瞻性记录数据以确定大出血的风险因素。死亡10例，非死亡22例，分别占0.11%和0.24%。与未出血的对照组相比，恶性肿瘤、年龄、性别和通过次数是唯一可预测的风险因素。恶性肿瘤患者的致死性出血风险估计为0.4%;非致死性出血风险为0.57%。在因非恶性疾病而接受肝活检的患者中，风险分别为0.04%和0.16%。
Nine thousand two hundred twelve liver biopsies were performed according to a defined protocol, and data were prospectively recorded to identify risk factors for major bleeding. There were 10 fatal and 22 nonfatal hemorrhages (0.11% and 0.24%, respectively). By comparison with a control group that did not hemorrhage, malignancy, age, sex, and the number of passes were the only predictable risk factors. The risk of fatal hemorrhage in patients with malignancy is estimated to be 0.4%; for nonfatal hemorrhage, 0.57%. In patients undergoing liver biopsy for nonmalignant disease, the risks are 0.04% and 0.16%, respectively.